Plain Language Summary of the iNNOVATE Study: Ibrutinib Plus Rituximab is Well-Tolerated and Effective in People with Waldenström's Macroglobulinemia — Christian Buske (2023) | RDL Network
Plain Language Summary of the iNNOVATE Study: Ibrutinib Plus Rituximab is Well-Tolerated and Effective in People with Waldenström's Macroglobulinemia
Letter 2023 en
Authors
CB
Christian Buske
AT
Alessandra Tedeschi
JT
Judith Trotman
Abstract
1 min read
These results show that ibrutinib plus rituximab is better than rituximab alone in people with WM and that ibrutinib plus rituximab is safe and effective in the long term. This information confirms the role of ibrutinib plus rituximab as a standard of care for WM. <b>Clinical Trial Registration</b>: NCT02165397 (ClinicalTrials.gov).
Meletios A Dimopoulos, Alessandra Tedeschi, Judith Trotman, Ramón García‐Sánz, D. Blair Macdonald, Véronique Leblond, Beatrice Mahé, Charles Herbaux, Constantine S. Tam, Lorella Orsucci, M. Lia Palomba, Jeffrey Matous, Chaim Shustik, Efstathios Kastritis, Steven P. Treon, Jianling Li, Zeena Salman, Thorsten Graef, Christian Buske
Alessandra Tedeschi, Meletios A Dimopoulos, Judith Trotman, Ramón García‐Sánz, D. Blair Macdonald, Beatrice Mahé, Charles Herbaux, Leonard T. Heffner, Constantine S. Tam, Marzia Varettoni, M. Lia Palomba, J. Matous, Chaim Shustik, Efstathios Kastritis, Steven P. Treon, J. Li, Erik Poulsen, B. Hauns, Christian Buske, V. Leblond
Alessandra Tedeschi, Meletios A Dimopoulos, Judith Trotman, Ramón García‐Sánz, D. Blair Macdonald, Beatrice Mahé, Charles Herbaux, Leonard T. Heffner, Constantine S. Tam, Marzia Varettoni, M. Lia Palomba, J. Matous, Chaim Shustik, Efstathios Kastritis, Steven P. Treon, J. Li, Erik Poulsen, B. Hauns, Christian Buske, V. Leblond
Meletios A Dimopoulos, Xavier Leleu, Jeffrey Matous, David MacDonald, Judith Trotman, Albert Oriol, Chaim Shustik, Alessandra Tedeschi, Ramón García‐Sánz, Leonard T. Heffner, Shuo Ma, Beatrice Mahé, Constantine S. Tam, Olivier Tournilhac, Jianling Li, Priyanka Singh, Elizabeth Bilotti, Thorsten Graef, Steven P. Treon, Christian Buske
Discussion(0)
No comments yet. Be the first to comment.